Avadel Pharmaceuticals plc - ADR

NASDAQ:AVDL  
8.23
+0.35 (+4.44%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Avadel Pharmaceuticals plc - ADR Stock, NASDAQ:AVDL

10 Earlsfort Terrace, Block 10-1, 2nd Floor, Dublin, Dublin 02
Phone: +353.1.485.1200
Number of Employees: 32

Description

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its products include Bloxiverz, Vazculep, Nouress, and Akovaz. It focuses on approval of FT218, a formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.